The Arthritis Foundation and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) host a patient-focused drug development meeting.

Read about past recipients of the Lee C. Howley Sr. Prize for Arthritis Scientific Research.

See how the Arthritis Foundation brings clinical research and crowd-sourcing together to benefit all those living with the disease in your community.

A patient-focused drug development meeting gives doctors, researches and health providers a chance to hear from Osteoarthritis (OA) sufferers directly.

The Arthritis Foundation works with families to shape new solutions to conquering childhood arthritis.

These investigators are currently engaged in Arthritis Foundation-funded Rheumatic disease research.

See how the Arthritis Foundation is unique in having a community and national research agenda that is defined by patient voice, using data that comes directly from the patient community.

David Felson, MD, MPH, is the recipient of 2020 Lee C. Howley Sr. Prize for his significant contributions to arthritis research.

The Arthritis Foundation is leading the way in advancing treatments for osteoarthritis, the most common form of arthritis, for which there currently are limited effective therapies.

See the Arthritis Foundation educational videos on the benefits available through participation in research.

The Arthritis Foundation partners with CARRA on The Registry, a tool to help answer important questions about these conditions.

See why we rely on PCORI and PCORnet to improve the quality of life and longevity of rheumatic disease patients.

Who is on the front line of the fight against rheumatic diseases? Learn more information about our many collaborators in the struggle against arthritis.

They stand at the leading edge of rheumatic disease research today. Meet the members of the Arthritis Foundations’ 2019 Medical and Scientific Committee.

Learn more about the Arthritis Foundation’s key partners in the search for the cure to arthritis.

Share your experience in a 10-minute assessment to be among those changing the future of arthritis.

The Arthritis Foundation is working to grow the number of rheumatoid specialists so that people can receive more in depth care.

Train emerging leaders and accelerate FDA approval of new therapies.

Guidance documents have been developed by the Arthritis Foundation for patients who want to learn more about stem cell research.

Join patients, care providers, researchers and physicians in PARTNERS, and help improve the lives of children with rheumatic diseases and their families.

The Arthritis Foundation is proud to have partnered with the American College of Rheumatology (ACR) on the release of two guidelines on juvenile idiopathic arthritis (JIA).

The Osteoarthritis Clinical Studies Forum Series features OA thought leaders from across the globe discussing the future of how the disease can be treated to improve patient outcomes.

Co-hosted by the FDA and the Arthritis Foundation on June 22, 2021

Presenters discussed many aspects of osteoarthritis and development of drugs to treat it, including its epidemiology, challenges to assessing disease progression, potential biomarkers, difficulties of evaluating long-term benefits to the patient and challenges to achieving FDA approval. View and download the supporting presentations below.

The first OA Clinical Studies forum highlights key international research.